Viking Therapeutics to start obesity drug mid-stage trial
...(Reuters) - Viking Therapeutics Inc said on Tuesday it will begin......…
33,190€
5,45%
Echtzeit-Aktienkurs Viking Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Viking Therapeutics Inc. Aktie
UPDATE 1-Viking Therapeutics to start obesity drug mid-stage trial
...(Adds trial details, shares )
March 28 (Reuters) - Viking......…
Viking Therapeutics Shares Surge Premarket on VK2735 Study Data >VKTX
Viking Therapeutics Shares Surge Premarket on VK2735 Study Data >VKTX...…
Is Viking Therapeutics a Smart Buy on the Dip?
The stock recently fell around 25% for reasons that had nothing to do with its lead program....…
Viking Therapeutics started at buy with $22 stock price target at Stifel Nicolaus
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Viking Therapeutics to Present at SVB Securities Global Biopharma Conference
SAN DIEGO, Feb. 7, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the…
Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Range of VK2809 Doses for up to 52 Weeks; Data for Primary Endpoint Expected…
Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints
HANGZHOU and SHAOXING, China, Jan. 2, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") was recently informed that on…